Boston Scientific Corporation (BSX) — closed signal from July 15, 2025
Partial Published before the outcome was known, scored automatically when the window closed on October 13, 2025.
Predicted vs. what happened
What happened
Reached 31% of the predicted growth at its peak, without hitting the target.
The thesis — published July 15, 2025
After a small 5% drop following recent U.S. regulator news, the share price slipped back to its recent average price, and trading showed 30% more shares changing hands on up days than normal, suggesting big investors are quietly building positions. The July 23 earnings report is likely to highlight the broader approval for Farapulse, a heart-rhythm product that early European sales show makes higher profits. Positive investor mood and more money moving into healthcare could lift the stock toward $117 within three months.
Primary drivers
- Heavy trading before July 23 results hints that big investors want more shares
- New U.S. approval lets Farapulse treat more AFib patients, expanding its customer base
- Price pullback reset short-term signs, so the chance of gain is now larger than loss
- Early European figures show Farapulse earns better profits, likely boosting forecasts
How it played out
BSX: target stayed out of reach
Lyra published BSX at 104.33 on 2025-07-15, with 16% expected growth and a 121.02 target. The thesis pointed to heavier up-day trading before July 23 results, broader U.S. approval for Farapulse, a pullback into the entry zone, and early European Farapulse figures that were expected to help forecasts.
Inside the window, BSX rose to 109.5 on 2025-09-09, a 5% peak gain. It never reached 121.02. By 2025-10-13, it ended at 94.95. The thesis partially played out on direction at the peak, but it missed the target and finished below the publication price.
What happened during the window
On 2025-07-23, Boston Scientific reported second-quarter results. Investors.com reported sales of $5.06 billion, adjusted earnings of $0.75 per share, and a raised 2025 outlook. MarketWatch reported that BSX closed at $107.76 on 2025-07-23 after that session.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.